An application to allow OTC access to an oral contraceptive soon could reach FDA. Proponents already are pushing for its review to be based solely on a safety and efficacy analysis that leaves customer age out of the equation.
Groups such as the Oral Contraceptives Over-the-Counter Working Group want to make sure that age, the controversial element in FDA’s...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?